Qube Research & Technologies Ltd - BIONTECH SE ownership

BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 288 filers reported holding BIONTECH SE in Q1 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of BIONTECH SE
ValueSharesWeighting
Q1 2023$7,544,831
-35.5%
60,567
-22.2%
0.03%
-49.2%
Q4 2022$11,690,271
+46.4%
77,821
+45.3%
0.06%
+6.8%
Q2 2022$7,985,000
+115.9%
53,556
+273.2%
0.06%
+103.4%
Q4 2021$3,699,000
-21.2%
14,349
-16.6%
0.03%
-50.8%
Q3 2021$4,697,000
+364.6%
17,204
+280.9%
0.06%
+391.7%
Q2 2021$1,011,000
+82.5%
4,517
-11.0%
0.01%
+33.3%
Q1 2021$554,000
-94.7%
5,077
-96.0%
0.01%
-93.9%
Q4 2020$10,398,000
+93.7%
127,555
+64.5%
0.15%
+92.2%
Q3 2020$5,367,000
+666.7%
77,519
+638.8%
0.08%
+670.0%
Q2 2020$700,000
+92.8%
10,492
+69.0%
0.01%
-33.3%
Q1 2020$363,0006,2090.02%
Other shareholders
BIONTECH SE shareholders Q1 2023
NameSharesValueWeighting ↓
Fosun International Ltd 1,003,640$149,643,00020.73%
Bill & Melinda Gates Foundation 148,674$22,200,00017.06%
Quinn Opportunity Partners LLC 300,721$44,838,0003.90%
PARUS FINANCE (UK) Ltd 42,953$6,404,0003.81%
Renaissance Capital LLC 36,476$5,439,0002.90%
Baader Bank Aktiengesellschaft 224,800$33,520,0002.58%
Tri Locum Partners LP 39,663$5,914,0002.42%
MARK ASSET MANAGEMENT LP 61,734$9,205,0002.22%
Franchise Capital Ltd 43,650$6,508,0002.18%
Boston Common Asset Management, LLC 283,776$42,311,0002.11%
View complete list of BIONTECH SE shareholders